This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Jun 1;111(11):5268.

doi: 10.1182/blood-2008-03-146878.

Lenalidomide: what is the right dose in CLL?

Affiliations

PMID: 18502842
DOI: 10.1182/blood-2008-03-146878

Free article

Comment

Lenalidomide: what is the right dose in CLL?

Thomas S Lin. Blood. 2008.

Free article

. 2008 Jun 1;111(11):5268.

doi: 10.1182/blood-2008-03-146878.

Author

Affiliation

¹ The Ohio State University.

PMID: 18502842
DOI: 10.1182/blood-2008-03-146878

No abstract available

PubMed Disclaimer

Comment on

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia.
Ferrajoli A, Lee BN, Schlette EJ, O'Brien SM, Gao H, Wen S, Wierda WG, Estrov Z, Faderl S, Cohen EN, Li C, Reuben JM, Keating MJ. Ferrajoli A, et al. Blood. 2008 Jun 1;111(11):5291-7. doi: 10.1182/blood-2007-12-130120. Epub 2008 Mar 11. Blood. 2008. PMID: 18334676 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems